Skip to main content
. 2021 May 31;7(6):439. doi: 10.3390/jof7060439

Table 3.

In vitro candidacidal activity of in silico designed peptides (ISDPs) against C. albicans SC5314.

Peptide EC50 1 (95% Confidence Intervals) EC50 ISDP/EC50 K10S
K10S 0.277 (0.274–0.279) 2 -
R10S-RR 0.254 (0.247–0.262) 0.92
K10T-TT 0.173 (0.171–0.175) 0.62
K10S-SS 0.159 (0.150–0.168) 0.57
K10S-I 0.260 (0.239–0.282) 0.94

1 EC50, half maximal effective concentration, [mol/liter] × 10−6; 2 EC50 of K10S parent peptide [19].